Torno Capital’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Torno Capital's KZR Position: Q2 2026 in Review
Torno Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 48,479 shares — an estimated $360K sold.
Torno Capital first reported a position in KZR in Q4 2025 and held it in 2 quarters. The position peaked at $360K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.
- Torno Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
- Torno Capital sold 48,479 Kezar Life Sciences shares in Q2 2026, an estimated $360K.
- Torno Capital first reported a position in Kezar Life Sciences in Q4 2025 and held it in 2 quarters.
- Torno Capital's Kezar Life Sciences position peaked at $360K in Q1 2026.
- 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.
Based on Torno Capital's 13F filing for Q2 2026, filed 14 Aug 2026.